| Course name |
Chemistry and technology of drugs |
|---|
| Study-unit Code |
A001807 |
|---|
| Location |
PERUGIA |
|---|
| Curriculum |
Comune a tutti i curricula |
|---|
| Lecturer |
Paolo Puccetti |
|---|
| Lecturers |
- Paolo Puccetti
- Claudia Volpi (Codocenza)
- Francesca Fallarino (Codocenza)
- Ciriana Orabona (Codocenza)
|
|---|
| Hours |
- 20 ore - Paolo Puccetti
- 20 ore (Codocenza) - Claudia Volpi
- 20 ore (Codocenza) - Francesca Fallarino
- 20 ore (Codocenza) - Ciriana Orabona
|
|---|
| CFU |
10 |
|---|
| Course Regulation |
Coorte 2019 |
|---|
| Supplied |
2021/22 |
|---|
| Supplied other course regulation |
|
|---|
| Learning activities |
Caratterizzante |
|---|
| Area |
Discipline biologiche e farmacologiche |
|---|
| Sector |
BIO/14 |
|---|
| Type of study-unit |
Obbligatorio (Required) |
|---|
| Type of learning activities |
Attività formativa monodisciplinare |
|---|
| Language of instruction |
English |
|---|
| Contents |
General principles of pharmacotherapy. Systematic pharmacology: the different families of drugs according to the therapeutic classification |
|---|
| Reference texts |
Waller, Renwick, Hillier. "Medical Pharmacology and Therapeutics" Third Edition Elsevier |
|---|
| Educational objectives |
Knowledge of drug therapy. Knowledge of pharmacological profile of the different therapeutic families, including main effects, side and secondary effects. |
|---|
| Prerequisites |
Having passed the exam of General Pharmacology, Pharmacognosy and Toxicology (for CTF) or General Pharmacology (for Biotechnology) |
|---|
| Teaching methods |
Face-to-face theoretical lessons |
|---|
| Other information |
Private Facebook Group |
|---|
| Learning verification modality |
Written exam with open answers |
|---|
| Extended program |
General principles of pharmacotherapy. The ADRs. Immunotoxicity and drug allergy. Pharmacology of monoclonal antibodies. Vaccines. Antineoplastic, antibacterial and antiviral chemotherapy: general principles and main group of drugs. The inflammatory process and its involvement in pathological diseases. NSAIDs. FAS. Rheumatoid arthritis therapy. Pharmacology of diabetes mellitus. Obesity pharmacotherapy. General information on the neurotransmission of the peripheral and central nervous system. Pharmacology of the cardiovascular system. Treatment of congestive heart failure and angina pectoris. Anti-hypertensive drugs. Diuretics. Pharmacotherapy of erectile dysfunction. Peptic ulcer therapy. Pain pharmacology and main classes of analgesic drugs. Pharmacotherapy of affective disorders (depression and anxiety). Schizophrenia therapy. Pharmacological therapy of Alzheimer's disease. Tolerance and addiction. |
|---|
